Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: A comparative study
Summary Background Despite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new treatment modalities and approaches are needed. Objective To evaluate the efficacy and safety of fractional carbon dioxide (CO2) laser therapy fo...
Saved in:
| Published in | Journal of cosmetic dermatology Vol. 18; no. 1; pp. 142 - 149 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
01.02.2019
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1473-2130 1473-2165 1473-2165 |
| DOI | 10.1111/jocd.12553 |
Cover
| Abstract | Summary
Background
Despite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new treatment modalities and approaches are needed.
Objective
To evaluate the efficacy and safety of fractional carbon dioxide (CO2) laser therapy followed by narrow band ultraviolet‐B (NB‐UVB) phototherapy on stable resistant vitiligo.
Subjects and methods
Thirty‐two patients with stable bilateral vitiligo were enrolled. For each patient, one side of the body was treated with NB‐UVB in addition to two sessions of fractional CO2 laser performed at 2‐months interval (laser side), while the other side was treated with NB‐UVB alone (control side). NB‐UVB was administrated twice weekly for 4 months. Outcomes were evaluated objectively based on standard digital photographs, patient satisfaction, and adverse effects.
Results
There was statistically significant improvement in the repigmentation in laser side compared to control side. Noticeable adverse events, such as infection, scarring, and Koebner phenomenon were not found in any patient.
Conclusions
Fractional CO2 laser therapy combined with NB‐UVB phototherapy could be used effectively and safely as an alternative modality for the treatment of vitiligo. It shortens the duration of NB‐UVB therapy and is expected to increase patient compliance |
|---|---|
| AbstractList | Despite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new treatment modalities and approaches are needed.BACKGROUNDDespite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new treatment modalities and approaches are needed.To evaluate the efficacy and safety of fractional carbon dioxide (CO2 ) laser therapy followed by narrow band ultraviolet-B (NB-UVB) phototherapy on stable resistant vitiligo.OBJECTIVETo evaluate the efficacy and safety of fractional carbon dioxide (CO2 ) laser therapy followed by narrow band ultraviolet-B (NB-UVB) phototherapy on stable resistant vitiligo.Thirty-two patients with stable bilateral vitiligo were enrolled. For each patient, one side of the body was treated with NB-UVB in addition to two sessions of fractional CO2 laser performed at 2-months interval (laser side), while the other side was treated with NB-UVB alone (control side). NB-UVB was administrated twice weekly for 4 months. Outcomes were evaluated objectively based on standard digital photographs, patient satisfaction, and adverse effects.SUBJECTS AND METHODSThirty-two patients with stable bilateral vitiligo were enrolled. For each patient, one side of the body was treated with NB-UVB in addition to two sessions of fractional CO2 laser performed at 2-months interval (laser side), while the other side was treated with NB-UVB alone (control side). NB-UVB was administrated twice weekly for 4 months. Outcomes were evaluated objectively based on standard digital photographs, patient satisfaction, and adverse effects.There was statistically significant improvement in the repigmentation in laser side compared to control side. Noticeable adverse events, such as infection, scarring, and Koebner phenomenon were not found in any patient.RESULTSThere was statistically significant improvement in the repigmentation in laser side compared to control side. Noticeable adverse events, such as infection, scarring, and Koebner phenomenon were not found in any patient.Fractional CO2 laser therapy combined with NB-UVB phototherapy could be used effectively and safely as an alternative modality for the treatment of vitiligo. It shortens the duration of NB-UVB therapy and is expected to increase patient compliance.CONCLUSIONSFractional CO2 laser therapy combined with NB-UVB phototherapy could be used effectively and safely as an alternative modality for the treatment of vitiligo. It shortens the duration of NB-UVB therapy and is expected to increase patient compliance. Summary Background Despite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new treatment modalities and approaches are needed. Objective To evaluate the efficacy and safety of fractional carbon dioxide (CO2) laser therapy followed by narrow band ultraviolet‐B (NB‐UVB) phototherapy on stable resistant vitiligo. Subjects and methods Thirty‐two patients with stable bilateral vitiligo were enrolled. For each patient, one side of the body was treated with NB‐UVB in addition to two sessions of fractional CO2 laser performed at 2‐months interval (laser side), while the other side was treated with NB‐UVB alone (control side). NB‐UVB was administrated twice weekly for 4 months. Outcomes were evaluated objectively based on standard digital photographs, patient satisfaction, and adverse effects. Results There was statistically significant improvement in the repigmentation in laser side compared to control side. Noticeable adverse events, such as infection, scarring, and Koebner phenomenon were not found in any patient. Conclusions Fractional CO2 laser therapy combined with NB‐UVB phototherapy could be used effectively and safely as an alternative modality for the treatment of vitiligo. It shortens the duration of NB‐UVB therapy and is expected to increase patient compliance Despite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new treatment modalities and approaches are needed. To evaluate the efficacy and safety of fractional carbon dioxide (CO ) laser therapy followed by narrow band ultraviolet-B (NB-UVB) phototherapy on stable resistant vitiligo. Thirty-two patients with stable bilateral vitiligo were enrolled. For each patient, one side of the body was treated with NB-UVB in addition to two sessions of fractional CO laser performed at 2-months interval (laser side), while the other side was treated with NB-UVB alone (control side). NB-UVB was administrated twice weekly for 4 months. Outcomes were evaluated objectively based on standard digital photographs, patient satisfaction, and adverse effects. There was statistically significant improvement in the repigmentation in laser side compared to control side. Noticeable adverse events, such as infection, scarring, and Koebner phenomenon were not found in any patient. Fractional CO laser therapy combined with NB-UVB phototherapy could be used effectively and safely as an alternative modality for the treatment of vitiligo. It shortens the duration of NB-UVB therapy and is expected to increase patient compliance. |
| Author | Doghaim, Noha Nabil Gheida, Shereen Farouk El‐Tatawy, Rania Ahmed Mohammed Ali, Dareen Abdelaziz |
| Author_xml | – sequence: 1 givenname: Noha Nabil surname: Doghaim fullname: Doghaim, Noha Nabil organization: Tanta University – sequence: 2 givenname: Shereen Farouk orcidid: 0000-0003-1833-3383 surname: Gheida fullname: Gheida, Shereen Farouk email: gheidas@yahoo.com organization: Tanta University – sequence: 3 givenname: Rania Ahmed surname: El‐Tatawy fullname: El‐Tatawy, Rania Ahmed organization: Tanta University – sequence: 4 givenname: Dareen Abdelaziz surname: Mohammed Ali fullname: Mohammed Ali, Dareen Abdelaziz organization: Tanta University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29707867$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUtv1DAUhS1URB-w4QcgLxHSFD-SOGbXDuWlSt10bzn2TXHl2IPtzDB_gt9cD2lZIIQ3vrK_c6R7zik6CjEAQq8pOaf1vL-Pxp5T1rb8GTqhjeArRrv26M_MyTE6zfmeECokbV-gYyYFEX0nTtCvdZwGF3RxMeA44jFpc5i1x0anoT5aF386C9jrDAnvXPmOg04p7vCgg8WzL0lvXfRQ8CUuEbtgZwM4wcbdTRDKYu0CzkUPHvDWFefdXfyAL7CJ00anSmyhfs92_xI9H7XP8OrxPkO3n65u119W1zefv64vrleGM8lX1nSSdk0PcjCCaCMF2KYjVDZdQ3rK5ChHblljWyC96YxltGfaUMJ5K0TPz9DbxXaT4o8ZclGTywa81wHinBUjnPWkRtpU9M0jOg8TWLVJbtJpr54irABZAJNizglGZdyydA3GeUWJOrSkDi2p3y1Vybu_JE-u_4TpAu-ch_1_SPXtZv1x0TwAKfKkGA |
| CitedBy_id | crossref_primary_10_1159_000537810 crossref_primary_10_1111_jdv_18005 crossref_primary_10_1111_dth_15635 crossref_primary_10_1111_dth_15821 crossref_primary_10_1111_dth_14604 crossref_primary_10_1007_s10103_020_03069_0 crossref_primary_10_4103_JCAS_JCAS_188_19 crossref_primary_10_1111_jocd_15267 crossref_primary_10_1089_photob_2021_0016 crossref_primary_10_1097_CM9_0000000000000794 crossref_primary_10_1111_jocd_15534 crossref_primary_10_1111_phpp_12740 crossref_primary_10_1007_s10103_025_04293_2 crossref_primary_10_1080_09546634_2018_1564232 crossref_primary_10_1097_DSS_0000000000003503 crossref_primary_10_1007_s10103_023_03879_y crossref_primary_10_1093_bjd_ljac074 crossref_primary_10_1111_jocd_14691 crossref_primary_10_4103_pigmentinternational_52_23 crossref_primary_10_1007_s10103_020_03195_9 crossref_primary_10_1093_asj_sjz250 crossref_primary_10_1016_j_ctcp_2022_101684 crossref_primary_10_3389_fcell_2023_1293101 |
| Cites_doi | 10.1016/j.jaad.2006.09.004 10.1002/lsm.22389 10.1111/j.1600-0781.2008.00385.x 10.1046/j.1524-4725.1999.99091.x 10.1111/j.1524-4725.2011.02127.x 10.1111/j.1365-2133.2011.10324.x 10.1111/phpp.12072 10.1111/j.1755-148X.2008.00528.x 10.1007/s10103-009-0734-8 10.1111/1523-1747.ep12480997 10.3109/14764172.2014.1003241 10.1111/j.1346-8138.2005.tb00847.x 10.4103/0019-5154.113944 10.1111/dth.12202 10.1067/mjd.2001.112357 10.3109/09546634.2011.579084 10.1007/s10103-016-1982-z 10.1046/j.1365-2133.2002.04900.x 10.1111/j.1365-2133.2011.10723.x 10.1111/j.1365-2133.2011.10564.x 10.1242/jcs.061598 10.1002/lsm.22260 10.1001/archderm.1997.03890480045006 |
| ContentType | Journal Article |
| Copyright | 2018 Wiley Periodicals, Inc. |
| Copyright_xml | – notice: 2018 Wiley Periodicals, Inc. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1111/jocd.12553 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1473-2165 |
| EndPage | 149 |
| ExternalDocumentID | 29707867 10_1111_jocd_12553 JOCD12553 |
| Genre | article Randomized Controlled Trial Journal Article Comparative Study |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 1OC 24P 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 52M 52O 52T 52U 52V 52W 53G 5GY 5HH 5VS 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANHP AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCMX ACCZN ACGFS ACMXC ACPOU ACRPL ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZCM ADZMN AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFGKR AFKRA AFPWT AFZJQ AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DRFUL DRMAN DRSTM EAD EAP EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F21 F5P FEDTE FUBAC FYUFA G-S G.N GODZA H.X HF~ HMCUK HVGLF HZ~ IHE KBYEO LATKE LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ O66 O9- OIG OVD OVEED P2P P2W P2X P2Z P4B P4D PIMPY Q.N QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 UKHRP V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WVDHM YFH YUY ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AGQPQ AGXDD AIDQK AIDYY CITATION PHGZM PHGZT PUEGO CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c3293-dc691648e9bc70ac97ed4601946408129f9f3d24d5e08c6cd2182ac103357783 |
| ISSN | 1473-2130 1473-2165 |
| IngestDate | Fri Jul 11 07:46:52 EDT 2025 Wed Feb 19 02:36:33 EST 2025 Thu Apr 24 22:57:34 EDT 2025 Wed Oct 01 03:17:11 EDT 2025 Wed Jan 22 16:48:56 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | vitiligo fractional CO2 laser NB-UVB |
| Language | English |
| License | 2018 Wiley Periodicals, Inc. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c3293-dc691648e9bc70ac97ed4601946408129f9f3d24d5e08c6cd2182ac103357783 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0003-1833-3383 |
| PMID | 29707867 |
| PQID | 2032801254 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_2032801254 pubmed_primary_29707867 crossref_citationtrail_10_1111_jocd_12553 crossref_primary_10_1111_jocd_12553 wiley_primary_10_1111_jocd_12553_JOCD12553 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | February 2019 2019-02-00 2019-Feb 20190201 |
| PublicationDateYYYYMMDD | 2019-02-01 |
| PublicationDate_xml | – month: 02 year: 2019 text: February 2019 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Journal of cosmetic dermatology |
| PublicationTitleAlternate | J Cosmet Dermatol |
| PublicationYear | 2019 |
| References | 2002; 16 2009; 22 2013; 29 2015; 17 2012; 166 1991; 97 1997; 133 2010; 123 1999; 25 2008 2016; 31 2014; 46 2011; 37 2001; 44 2007; 56 2015; 28 2013; 58 2010; 25 2012; 1 2002; 147 2008; 24 2005; 32 2012; 23 2016; 48 2016; 25 2011; 165 Ortonne J (e_1_2_6_3_1) 2008 e_1_2_6_10_1 e_1_2_6_19_1 Shahmoradi Z (e_1_2_6_2_1) 2012; 1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_11_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 e_1_2_6_21_1 e_1_2_6_20_1 Rubaie S (e_1_2_6_5_1) 2002; 16 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_23_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_27_1 Kubanov A (e_1_2_6_12_1) 2016; 25 e_1_2_6_26_1 |
| References_xml | – volume: 24 start-page: 322 year: 2008 end-page: 329 article-title: Effect of one session of ER:YAG laser ablation plus topical 5 Fluorouracil on the outcome of short‐term NB‐UVB phototherapy in the treatment of non‐segmental vitiligo: a left‐right comparative study publication-title: Photodermatol Photoimmunol Photomed – volume: 25 start-page: 5 year: 2016 end-page: 9 article-title: Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan‐a marker publication-title: Acta Dermatovenerologica – volume: 28 start-page: 131 year: 2015 end-page: 134 article-title: Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half‐body, comparative study publication-title: Dermatol Ther – volume: 133 start-page: 1525 year: 1997 end-page: 1528 article-title: Treatment of vitiligo with UV‐B radiation vs topical psoralen plus UV‐A publication-title: Arch Dermatol – volume: 48 start-page: 197 year: 2016 end-page: 202 article-title: Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult‐to‐treat areas publication-title: Lasers Surg Med – volume: 46 start-page: 443 year: 2014 end-page: 448 article-title: Fractional laser for vitiligo treated by 10600 nm Ablative fractional carbon dioxide laser followed by sun exposure publication-title: Laser Surg Med – volume: 31 start-page: 1343 year: 2016 end-page: 1349 article-title: A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo publication-title: Lasers Med Sci – volume: 44 start-page: 634 year: 2001 end-page: 637 article-title: Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study publication-title: J Am Acad Dermatol – volume: 166 start-page: 658 year: 2012 end-page: 661 article-title: Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrow band ultraviolet B in refractory non –segmental vitiligo: aprospective, randomized half body comparative study publication-title: Br Ass Dermatol – volume: 1 start-page: 17 year: 2012 end-page: 23 article-title: Comparing the efficacy of topical clobetasol plus 5‐flurouracil 5% cream vs. topical clobitasol 0.o5% alone in treatment of vitiligo publication-title: Med Sci Res – volume: 29 start-page: 311 year: 2013 end-page: 317 article-title: Psoralen– narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone publication-title: Photodermatol Photoimmunol Photomed – volume: 25 start-page: 851 year: 1999 end-page: 856 article-title: A pilot study of in vivo immediate tissue contraction with CO2 skin laser resurfacing in a live farm pig publication-title: Dermatol Surg – start-page: 913 year: 2008 end-page: 963 – volume: 123 start-page: 853 year: 2010 end-page: 860 article-title: Human dermal stem cells differentiate into functional epidermal melanocytes publication-title: J Cell Sci – volume: 56 start-page: 274 year: 2007 end-page: 278 article-title: Efficacy, predictors of response and long term follow up in patient with vitiligo treated with NB UVB phototherapy publication-title: J Am Acad Dermatol – volume: 147 start-page: 946 year: 2002 end-page: 949 article-title: Cosmetic camouflage advice improves quality of life publication-title: Br J Dermatol – volume: 37 start-page: 1763 year: 2011 end-page: 1766 article-title: Combination of microdermabration and 5‐flurouracil to induce repigmentation in vitiligo publication-title: Dermatol Surg – volume: 32 start-page: 793 year: 2005 end-page: 800 article-title: Narrow band UV treatment of vitiligo in Chinese publication-title: J Dermatol – volume: 165 start-page: 285 year: 2011 end-page: 291 article-title: Altered levels of Ets‐1 transcription factor and matrix metallo proteinases in melanocytes from patients with vitiligo publication-title: Br J Dermatol – volume: 25 start-page: 137 year: 2010 end-page: 144 article-title: Fractional photothermolysis ‐ an update publication-title: Lasers Med Sci – volume: 16 start-page: 270 year: 2002 article-title: An open randomised study of treatment of 39 patient of generalized vitiligo with narrow –band UVB versus topical calcipotriol 1 PU versus PUVA therapy for 6‐12 months publication-title: J Eur Acad Derm Venereol Supplement – volume: 166 start-page: 208 year: 2012 end-page: 211 article-title: Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations publication-title: Br J Dermatol – volume: 58 start-page: 325 year: 2013 article-title: Phototherapy in vitiligo: assessing the compliance, response and patient's perception about disease and treatment publication-title: Indian J Dermatol – volume: 97 start-page: 410 year: 1991 end-page: 416 article-title: Role of hair follicles in the repigmentation of vitiligo publication-title: J Invest Dermatol – volume: 22 start-page: 42 year: 2009 end-page: 65 article-title: Update of skin repigmentation therapies in vitiligo publication-title: Pigment Cell Melanoma Res – volume: 23 start-page: 443 year: 2012 end-page: 448 article-title: Treatment of localized non–segmental vitiligo with intradermal 5‐flurouracil injection combined with narrow –band ultraviolet publication-title: J Dermatolog Treat – volume: 17 start-page: 216 year: 2015 end-page: 223 article-title: Carbon dioxide laser plus topical 5‐fluorouracil: a new combination therapeutic modality for acral vitiligo publication-title: J Cosmet Laser Ther – ident: e_1_2_6_6_1 doi: 10.1016/j.jaad.2006.09.004 – ident: e_1_2_6_15_1 doi: 10.1002/lsm.22389 – ident: e_1_2_6_18_1 doi: 10.1111/j.1600-0781.2008.00385.x – ident: e_1_2_6_25_1 doi: 10.1046/j.1524-4725.1999.99091.x – ident: e_1_2_6_8_1 doi: 10.1111/j.1524-4725.2011.02127.x – volume: 1 start-page: 17 year: 2012 ident: e_1_2_6_2_1 article-title: Comparing the efficacy of topical clobetasol plus 5‐flurouracil 5% cream vs. topical clobitasol 0.o5% alone in treatment of vitiligo publication-title: Med Sci Res – ident: e_1_2_6_27_1 doi: 10.1111/j.1365-2133.2011.10324.x – ident: e_1_2_6_10_1 doi: 10.1111/phpp.12072 – ident: e_1_2_6_7_1 doi: 10.1111/j.1755-148X.2008.00528.x – ident: e_1_2_6_28_1 doi: 10.1007/s10103-009-0734-8 – volume: 16 start-page: 270 year: 2002 ident: e_1_2_6_5_1 article-title: An open randomised study of treatment of 39 patient of generalized vitiligo with narrow –band UVB versus topical calcipotriol 1 PU versus PUVA therapy for 6‐12 months publication-title: J Eur Acad Derm Venereol Supplement – ident: e_1_2_6_22_1 doi: 10.1111/1523-1747.ep12480997 – ident: e_1_2_6_17_1 doi: 10.3109/14764172.2014.1003241 – start-page: 913 volume-title: Dermatology year: 2008 ident: e_1_2_6_3_1 – ident: e_1_2_6_23_1 doi: 10.1111/j.1346-8138.2005.tb00847.x – ident: e_1_2_6_13_1 doi: 10.4103/0019-5154.113944 – ident: e_1_2_6_16_1 doi: 10.1111/dth.12202 – ident: e_1_2_6_11_1 doi: 10.1067/mjd.2001.112357 – ident: e_1_2_6_21_1 doi: 10.3109/09546634.2011.579084 – ident: e_1_2_6_20_1 doi: 10.1007/s10103-016-1982-z – volume: 25 start-page: 5 year: 2016 ident: e_1_2_6_12_1 article-title: Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan‐a marker publication-title: Acta Dermatovenerologica – ident: e_1_2_6_24_1 doi: 10.1046/j.1365-2133.2002.04900.x – ident: e_1_2_6_9_1 doi: 10.1111/j.1365-2133.2011.10723.x – ident: e_1_2_6_14_1 doi: 10.1111/j.1365-2133.2011.10564.x – ident: e_1_2_6_26_1 doi: 10.1242/jcs.061598 – ident: e_1_2_6_19_1 doi: 10.1002/lsm.22260 – ident: e_1_2_6_4_1 doi: 10.1001/archderm.1997.03890480045006 |
| SSID | ssj0017915 |
| Score | 2.2784526 |
| Snippet | Summary
Background
Despite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new... Despite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new treatment modalities... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 142 |
| SubjectTerms | Adolescent Adult Combined Modality Therapy Female fractional CO2 laser Humans Lasers, Gas - adverse effects Lasers, Gas - therapeutic use Male NB‐UVB Patient Satisfaction Photography Prospective Studies Single-Blind Method Skin Pigmentation - radiation effects Ultraviolet Therapy - adverse effects vitiligo Vitiligo - pathology Vitiligo - radiotherapy Young Adult |
| Title | Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: A comparative study |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.12553 https://www.ncbi.nlm.nih.gov/pubmed/29707867 https://www.proquest.com/docview/2032801254 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1473-2165 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017915 issn: 1473-2130 databaseCode: ABDBF dateStart: 20020901 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVOVD databaseName: Journals@Ovid LWW All Open Access Journal Collection Rolling customDbUrl: eissn: 1473-2165 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017915 issn: 1473-2130 databaseCode: OVEED dateStart: 20020101 isFulltext: true titleUrlDefault: http://ovidsp.ovid.com/ providerName: Ovid |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJyFeEHfKTUbwAlWmxHFuvHVrxzRp20tBe4sc220jtQ3KUkD7EfxP_gXHl7opHWjwEqVW4rQ9X-xz7PN9B6G3fkgykkaxF8cT4tGAh14qKIePMklCwmREFN_59Cw-_kRPLqKLTudnK2tp1RT7_OpaXsn_WBXawK6KJfsPlnWdQgOcg33hCBaG441sDC8zBLbO6ZvUhqWgJD9YXUCjKKvvpZB9cJFlbdZcl1p1sV-oBfPVvKmZ3ppv-gfKC4UAHUytNhLK6cKyknQqJPiQimL1tWzKeTmtDJ-dt5TDNzK1u54ury4XiivZF2oaaLYW8ofVdMZMReezasZgtC82SR8fZ7IU2rtVCpIqneyI1dXKkYtGc5erMWYN-2YAwxTRbDBbWNqWziieqQV60R_MLa9edzYolETmVXnVXvpQbCuXRmJGa5qEHgnsxo5st5kCFLtDvIOyGa8DI-1lp_7AqKf-aVapuNgHf9CIG29Ld_82pbpERxdiwb25vvcW2iMwAfldtHf-eTQaui2vJNPlNtxvslq6Ou3MPXnbe9oJibYjLO0ije-hu9bieGCAeh915PIBun1qszceoh8tvOJqgjd4xQav2OIVa7xihVds8IoVXnELr_gANxU2eMXbeIVWbPCK13j9gAe4hVas0foIjY9G48Njz9YD8TiMKKEneAzBDE1lVvDEZzxLpKAx4ILGFDxbkk2ySSgIFZH0Ux5zoaoTMB74YRglSRo-Rt1ltZRPEU6hgyQgDIIPQQsaprFfCOaTBD5KweIeerf-m3NutfJVyZZ5vmvQHnrjrv1iFGKuver12lo5DOBqV44tZbW6zIlStAQ3MaI99MSY0fVDMiXGFSc99F7b9S8PyE_OD4f67NmNvtBzdGfzSr1A3aZeyZfgXzfFK4vMXy_o1Z4 |
| linkProvider | Ovid |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combination+of+fractional+carbon+dioxide+laser+with+narrow+band+ultraviolet+B+to+induce+repigmentation+in+stable+vitiligo%3A+A+comparative+study&rft.jtitle=Journal+of+cosmetic+dermatology&rft.au=Doghaim%2C+Noha+Nabil&rft.au=Gheida%2C+Shereen+Farouk&rft.au=El%E2%80%90Tatawy%2C+Rania+Ahmed&rft.au=Mohammed+Ali%2C+Dareen+Abdelaziz&rft.date=2019-02-01&rft.issn=1473-2130&rft.eissn=1473-2165&rft.volume=18&rft.issue=1&rft.spage=142&rft.epage=149&rft_id=info:doi/10.1111%2Fjocd.12553&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jocd_12553 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-2130&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-2130&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-2130&client=summon |